Latest news and press releases about SeaStar Medical Holding Corporation (ICU): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
SeaStar Medical Holding Corporation is a medical device company dedicated to providing innovative solutions and services designed to combat hyperinflammation and cytokine storm in critically ill individuals.
Price
| Price | $3.08 |
| Market Cap | $9M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 3.00 |
| EV / EBITDA | -0.11 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -162.75% |
| Return on Invested Capital | -325.63% |
| Return on Assets | -157.56% |
| Gross Margin | 92.64% |
| Operating Margin | -816.64% |
| Net Margin | -795.50% |
Related companies: ADTX · AIMD · APLM · ATHA · BLRX · CTXR · LNAI
Explore sector: Healthcare · Biotechnology
More sections of ICU: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks